Ferritin Light Chain Antibody [N23F20]

Catalog No.: F2743

    Application: Reactivity:

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:100
    1:50
    1:500
    Application
    IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years

    Datasheet & SDS

    生物学的記述

    Specificity
    Ferritin Light Chain Antibody [N23F20] detects endogenous levels of total Ferritin Light Chain protein.
    Clone
    N23F20
    Synonym(s)
    Ferritin light chain; Ferritin L subunit; FTL
    Background
    Ferritin light chain (FTL), encoded by the FTL gene on chromosome 19q13.33, is one of two subunits (with ferritin heavy chain, FTH) that self-assemble into a 24-meric hollow spherical nanocage (~450 kDa) serving as the primary intracellular iron storage protein across eukaryotes. Each FTL monomer adopts a compact globular fold with a five α-helical bundle (A-E helices) forming the subunit core; 24 FTL/FTH subunits oligomerize via hydrophobic inter-subunit contacts at 4-fold (ferric iron entry channels) and 3-fold (iron nucleation/release pores) symmetry axes, creating a ~80 Å diameter central cavity lined by acidic residues (Glu, Asp) that nucleate ferrihydrite mineral core formation. Unlike FTH's ferroxidase center, FTL lacks catalytic residues (Glu27, Tyr34, Glu62, Gln141, and Glu107 are absent) but facilitates Fe(III) precipitation through surface phosphate-binding sites and iron channel clusters. FTL promotes long-term iron storage by accelerating ferrihydrite nucleation, detoxifying labile iron pool to prevent Fenton-mediated ROS damage, regulates translationally by iron-responsive element (IRE)/IRP1 binding in its 5' UTR; tissue-specific H/L ratios modulate iron kinetics (L-rich slower release). FTL mutations cause hereditary hyperferritinemia-cataract syndrome (upregulated apo-ferritin), neurodegeneration with brain iron accumulation (NBIA3), and contribute to cancer.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください